切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - eIF4F - adrenergic receptor - EP300 - Pyk2

10 件产品

每页
清除全部
  1. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  2. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  3. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  4. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2抑制剂
      ≥26.35 mg/mL
      insoluble in H2O
  5. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: 有效的ATP竞争性FAK/Pyk2抑制剂
      ≥11.1 mg/mL
      insoluble in H2O
  6. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP竞争性的FAK抑制剂。
      ≥25.35 mg/mL
      insoluble in H2O
  7. SGC-CBP30
    A4491 SGC-CBP30
     2 Citation
    Target: CREBBP|EP300
    Summary: CREBBP/EP300 bromodomain抑制剂
      ≥20.05 mg/mL
      ≥4.67 mg/mL
  8. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain抑制剂
      ≥49.6 mg/mL
      insoluble in H2O
  9. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  10. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O

10 件产品

每页